| Stereochemistry | ABSOLUTE |
| Molecular Formula | C17H25ClN2O3 |
| Molecular Weight | 340.845 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN1CCC[C@H]1CNC(=O)C2=C(O)C(CC)=CC(Cl)=C2OC
InChI
InChIKey=AADCDMQTJNYOSS-LBPRGKRZSA-N
InChI=1S/C17H25ClN2O3/c1-4-11-9-13(18)16(23-3)14(15(11)21)17(22)19-10-12-7-6-8-20(12)5-2/h9,12,21H,4-8,10H2,1-3H3,(H,19,22)/t12-/m0/s1
Eticlopride {2S(−)-3-chloro-5-ethyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-hydroxy-2-methoxybenzamide} is an antagonist at dopamine D2 and D3 receptors. It is widely used for in vivo, in vitro, and ex vivo examination of D2/D3 receptors densities and function. Eticlopride exerts antipsychotic activity in animals.
CNS Activity
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 0.5 nM [Ki] | |||
| 0.16 nM [Ki] | |||
| 0.08 nM [Ki] | |||
| 0.134 nM [Ki] | |||
| 7.0 null [pKi] |
PubMed
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
